AAAAAA

   
Results: 1-7 |
Results: 7
ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA
Authors: ETON O KHARKEVITCH DD GIANAN MA ROSS MI ITOH K PRIDE MW DONAWHO C BUZAID AC MANSFIELD PF LEE JE LEGHA SS PLAGER C PAPADOPOULOS NE BEDIKIAN AY BENJAMIN RS BALCH CM
Citation: O. Eton et al., ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA, Clinical cancer research, 4(3), 1998, pp. 619-627
ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA
Authors: ETON O KHARKEVITCH DD GIANAN MA ROSS MI ITOH K PRIDE MW DONAWHO C BUZAID AC MANSFIELD PF LEE JE LEGHA SS PLAGER C PAPADOPOULOS NE BEDIKIAN AY BENJAMIN RS BALCH CM
Citation: O. Eton et al., ACTIVE IMMUNOTHERAPY WITH ULTRAVIOLET B-IRRADIATED AUTOLOGOUS WHOLE MELANOMA-CELLS PLUS DETOX IN PATIENTS WITH METASTATIC MELANOMA, Clinical cancer research, 4(3), 1998, pp. 619-627
EVALUATION OF OCULAR SAFETY - TIRAPAZAMINE PLUS CISPLATIN IN PATIENTSWITH METASTATIC MELANOMAS
Authors: PRAGER TC KELLAWAY J ZOU YL URSO RG MCINTYRE S BEDIKIAN AY
Citation: Tc. Prager et al., EVALUATION OF OCULAR SAFETY - TIRAPAZAMINE PLUS CISPLATIN IN PATIENTSWITH METASTATIC MELANOMAS, Anti-cancer drugs, 9(6), 1998, pp. 515-524
PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED SYSTEMICALLY FOR DISSEMINATED MELANOMA
Authors: ETON O LEGHA SS MOON TE BUZAID AC PAPADOPOULOS NE PLAGER C BURGESS AM BEDIKIAN AY RING S DONG Q GLASSMAN AB BALCH CM BENJAMIN RS
Citation: O. Eton et al., PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED SYSTEMICALLY FOR DISSEMINATED MELANOMA, Journal of clinical oncology, 16(3), 1998, pp. 1103-1111
PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA
Authors: BEDIKIAN AY LEGHA SS ETON O BUZAID AC PAPADOPOULOS N COATES S SIMMONS T NEEFE J VONROEMELING R
Citation: Ay. Bedikian et al., PHASE-II TRIAL OF TIRAPAZAMINE COMBINED WITH CISPLATIN IN CHEMOTHERAPY OF ADVANCED MALIGNANT-MELANOMA, Annals of oncology, 8(4), 1997, pp. 363-367
PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY
Authors: BEDIKIAN AY WEISS GR LEGHA SS BURRIS HA ECKARDT JR JENKINS J ETON O BUZAID AC SMETZER L VONHOFF DD BENJAMIN RS
Citation: Ay. Bedikian et al., PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH ADVANCED CUTANEOUS MALIGNANT-MELANOMA PREVIOUSLY UNTREATED WITH CHEMOTHERAPY, Journal of clinical oncology, 13(12), 1995, pp. 2895-2899
TREATMENT OF UVEAL MELANOMA METASTATIC TO THE LIVER - A REVIEW OF THEM-D-ANDERSON-CANCER-CENTER EXPERIENCE AND PROGNOSTIC FACTORS
Authors: BEDIKIAN AY LEGHA SS MAVLIGIT G CARRASCO CH KHORANA S PLAGER C PAPADOPOULOS N BENJAMIN RS
Citation: Ay. Bedikian et al., TREATMENT OF UVEAL MELANOMA METASTATIC TO THE LIVER - A REVIEW OF THEM-D-ANDERSON-CANCER-CENTER EXPERIENCE AND PROGNOSTIC FACTORS, Cancer, 76(9), 1995, pp. 1665-1670
Risultati: 1-7 |